Home Whistleblower Claims Warner Chilcott Kickback Scheme

Warner Chilcott Kickback Scheme

Seeger Weiss represented the whistleblowers in a False Claims Act qui tam case that alleged a pay-to-prescribe scheme by drug manufacturer Warner Chilcott, resulting in a $125 million recovery by the United States and various state governments.

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Last updated: Apr 17, 2024
Warner Chilcott Kickback Scheme

What’s on this page:

Firm News

April 1, 2026
Seeger Weiss Welcomes Former Assistant U.S. Attorney Michael Castiglione as Firm Continues to Build Deep Bench of Talented Attorneys

Seeger Weiss is proud to announce that Michael Castiglione has joined the firm as Counsel, bringing nearly two decades of experience in in high-stakes litigation, government investigations, and complex civil matters. Castiglione comes to Seeger Weiss following more than a decade as an Assistant United States Attorney (AUSA) in the Eastern District of New York, […]

Read More
March 30, 2026
Ten Seeger Weiss Attorneys Named To The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers Guide

Seeger Weiss is proud to announce that ten Seeger Weiss attorneys have been selected for inclusion in The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Shauna Itri, Jeremy Kasha, Jennifer Scullion, and Caleb Seeley on this well-deserved recognition. […]

Read More
March 26, 2026
Jury Finds Meta and YouTube Liable in Landmark California Social Media Addiction Trial

A California jury has found Meta and YouTube negligent in designing platforms that harmed a young user, ordering Meta to pay $4.2 million and YouTube to pay $1.8 million in combined compensatory and punitive damages, in what is being called a landmark verdict in social media addiction litigation. Seeger Weiss Founding Partner Christopher Seeger serves […]

Read More
March 12, 2026
Seeger Weiss Partner Parvin Aminolroaya and Counsel Max Kelly Appointed to Leadership Roles in GLP-1 NAION Products Liability Litigation

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been appointed Co-Lead Counsel for Plaintiffs in the In Re: GLP-1 RAS Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation and Counsel Max Kelly has been appointed to the Plaintiffs’ Executive Committee. The litigation involves claims that GLP-1 receptor agonist drugs including Ozempic, Wegovy, […]

Read More